From: Outcomes measures in a decade of dementia and mild cognitive impairment trials
n (%) | |
---|---|
Source | |
Peer-reviewed publications | 630 (78) |
Unpublished | 128 (16) |
Conference abstracts | 47 (6) |
Intervention | |
Pharmacological | 487 (60) |
Non-pharmacological | 311 (39) |
Both | 7 (1) |
Registration/publication | |
2004 | 40 (5) |
2005 | 54 (7) |
2006 | 68 (8) |
2007 | 79 (10) |
2008 | 99 (12) |
2009 | 125 (16) |
2010 | 68 (8) |
2011 | 96 (12) |
2012 | 59 (7) |
2013 | 80 (10) |
2014 | 33 (4) |
2015a | 4 (0.5) |
Region | |
Asia | 133 (17) |
Australasia | 27 (3) |
Europe | 249 (31) |
Internationalb | 46 (6) |
Middle East | 11 (1) |
North America | 231 (29) |
Russia | 13 (2) |
South America | 16 (2) |
Unclear | 79 (10) |
Dementia subtype | |
Alzheimer’s disease | 398 (49) |
Dementia (unspecified) | 158 (20) |
Dementia and mild cognitive impairment | 30 (4) |
Frontotemporal dementia | 11 (1) |
Mild cognitive impairment | 123 (15) |
Mixedc | 39 (5) |
Parkinson’s disease dementia/dementia with Lewy bodies | 22 (3) |
Vascular dementia | 24 (3) |
Journal of publication (n = 630) | |
Old age psychiatry & dementia | 195 (31) |
Geriatric medicine & gerontology | 110 (17) |
Neurology & neuroscience | 95 (15) |
General medicine | 47 (7) |
Pharmacology | 44 (7) |
Complementary & alternative medicine | 27 (4) |
Psychiatry | 22 (3) |
Rehabilitation | 20 (3) |
Nursing | 18 (3) |
Nutrition | 9 (1) |
Psychology | 8 (1) |
Other | 35 (6) |